BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MH, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ. NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clinical and Translational Radiation Oncology 2022;33:66-9. [DOI: 10.1016/j.ctro.2021.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou C, Chen X, Huang Y, Zhang Q, Zhu S, Fu W. Nanomaterial Technology and Soft Tissue Sarcomas. Front Oncol 2022;12:921983. [DOI: 10.3389/fonc.2022.921983] [Reference Citation Analysis]
2 Dennahy IS, Han Z, Maccuaig WM, Chalfant HM, Condacse A, Hagood JM, Claros-sorto JC, Razaq W, Holter-chakrabarty J, Squires R, Edil BH, Jain A, Mcnally LR. Nanotheranostics for Image-Guided Cancer Treatment. Pharmaceutics 2022;14:917. [DOI: 10.3390/pharmaceutics14050917] [Reference Citation Analysis]